MOACM
AMRI

Mutual of America Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Mutual of America Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-134,625
Closed -$2.92M – 1233
2017
Q2 		$2.92M Buy
134,625
+1,137
+0.9% +$20.6K 0.05% 633
2017
Q1 		$1.87M Buy
133,488
+995
+0.8% +$16.3K 0.03% 832
2016
Q4 		$2.49M Buy
132,493
+3,917
+3% +$66.6K 0.05% 675
2016
Q3 		$2.12M Buy
128,576
+28,345
+28% +$420K 0.04% 724
2016
Q2 		$1.35M Buy
100,231
+2,694
+3% +$39.3K 0.03% 898
2016
Q1 		$1.49M Sell
97,537
-60,862
-38% -$954K 0.03% 811
2015
Q4 		$3.14M Buy
158,399
+8,689
+6% +$165K 0.07% 413
2015
Q3 		$2.61M Sell
149,710
-71,423
-32% -$1.45M 0.06% 496
2015
Q2 		$4.47M Buy
221,133
+12,750
+6% +$246K 0.1% 262
2015
Q1 		$3.67M Sell
208,383
-300
-0.1% -$5.11K 0.08% 379
2014
Q4 		$3.4M Buy
208,683
+187,883
+903% +$3.45M 0.08% 409
2014
Q3 		$459K Buy
+20,800
New +$426K 0.01% 1124

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mutual of America Capital Management's AMRI Position: Q3 2017 in Review

Mutual of America Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 134,625 shares — an estimated $2.92M sold.

Mutual of America Capital Management first reported a position in AMRI in Q3 2014 and held it in 12 quarters. The position peaked at $4.47M in Q2 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Mutual of America Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Mutual of America Capital Management sold 134,625 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.92M.
  • Mutual of America Capital Management first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 12 quarters.
  • Mutual of America Capital Management's Albany Molecular Research Inc position peaked at $4.47M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Mutual of America Capital Management's 13F filing for Q3 2017, filed 18 Oct 2017.